Myelodysplastic Syndromes (MDS)

Biting into the Elephant

I believe that a story is the shortest distance between two people. While this is my story, it is not just mine, and I did not do any of this alone. In April 1983, my husband Joe and I were 25 years old and attending to the required pre-marital blood work. Next thing we knew, we were sitting in a doctor’s office because my blood counts were abnormally low. They told us there was something wrong, but they didn’t know what it was.

Clear Communication with Your Provider

Today, limited appointment times, overwhelming and confusing volumes of information available on the Internet, coupled with the stress of having a rare disease diagnosis, might mean patients don't always get the answers they need to make informed decisions about their care. Clear communication can  have a positive impact on patient satisfaction, treatment adherence, and self-management.  Improving communication in any relationship is helped by respect for each other and the ability to manage expectations.

Nursing Education Modules on MDS Disease Management and Patient Education

Innovations in the diagnosis, risk stratification, and treatment of myelodysplastic syndromes (MDS) provide hope for patients while creating challenges for their health care providers. Nurses play an integral role in providing patients with clear explanations, setting treatment expectations, and empowering them to be actively in their care decisions. 

Kirk R. Schultz, MD

Institution
British Columbia Children’s Hospital
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Pediatric
About
Dr. Kirk Schultz is a Professor at the University of British Columbia, BC Children’s Hospital, and the Child and Family research Institute (CFRI) who has published over 130 peer-reviewed articles in scientific journals. He is a Pediatric Hematologist/Oncologist focused on new therapies and rejection in Blood and Marrow Transplantation (BMT) and immune therapy of blood cancers.Dr. Schultz was the recipient of the CIHR/Wyeth Clinical Research Chair in Transplantation and is past chair of the Pediatric BMT Consortium the largest children’s BMT clinical trials group in the world. He was recently

Lukasz Gondek, M.D., Ph.D.

Institution
Johns Hopkins University School of Medicine
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
About
Dr. Gondek is a current Evans Fellow at Johns Hopkins University in the Department of Oncology, working with Dr. Amy Dezern on research related to signaling pathways in MDS stem cells. Dr. Gondek explained that the mechanism of progression in MDS is poorly understood, and he hopes through his work to clarify some of the factors that contribute to progression. He is the Principal Investigator on one pilot project currently underway within the MDS Clinical Research Consortium, working with a particular signaling pathway named the Hedgehog pathway. Dr. Gondek describes the Hedgehog (Hh) pathway

David Margolis, MD

Institution
Children’s Hospital of Wisconsin
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric
About
David Margolis, MD, received his medical degree from the University of Wisconsin-Madison in 1989. He is currently a professor of pediatrics at the Medical College of Wisconsin, located in Milwaukee, and is program director of Children’s Hospital of Wisconsin’s Blood and Bone Marrow Transplant Program. His clinical and research interests include taking care of children and young adults with aplastic anemia as well as alternative donor blood and bone marrow transplants for children and young adults with aplastic anemia, sickle cell anemia and leukemia.

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.